- Home
- XNDU vs ALKS Comparison
XNDU vs ALKS Comparison
Compare XNDU & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XNDU | ALKS |
|---|---|---|
| Founded | 2016 | 1987 |
| Country | Canada | Ireland |
| Employees | 264 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 6.1B |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | XNDU | ALKS |
|---|---|---|
| Price | $15.84 | $42.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $44.00 | $43.43 |
| AVG Volume (30 Days) | ★ 8.0M | 2.1M |
| Earning Date | N/A | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,475,899,000.00 |
| Revenue This Year | N/A | $24.26 |
| Revenue Next Year | N/A | $4.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.97 | $25.17 |
| 52 Week High | $42.44 | $42.83 |
Technical Indicators
Market Signals| Indicator | XNDU | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 48.78 | 77.75 |
| Support Level | $11.81 | $27.65 |
| Resistance Level | $19.42 | N/A |
| Average True Range (ATR) | 1.63 | 1.49 |
| MACD | 0.12 | 0.43 |
| Stochastic Oscillator | 54.66 | 94.67 |
Price Performance
Historical ComparisonAbout XNDU Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares
Xanadu Quantum Technologies Ltd specializes in designing photonic devices and the platforms around them, including the experimentation and development of quantum computers available on the cloud with supporting software, along with quantum simulators and other related products and offerings. Its products include: Aurora, PennyLane, Catalyst, Lightning, Catalyst and PennyLane Codebook. The company operates in industries such as automotive, aerospace, energy, materials, and semiconductor sectors.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.